API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2022/10/25/2541307/0/en/Corvus-Pharmaceuticals-Announces-Initiation-of-Phase-1b-2-Clinical-Trial-of-Ciforadenant-as-Potential-First-Line-Treatment-for-Patients-with-Renal-Cell-Cancer.html
https://www.globenewswire.com/news-release/2020/05/13/2033077/0/en/Corvus-Pharmaceuticals-to-Present-Data-on-Refinement-of-the-Adenosine-Gene-Signature-and-Ciforadenant-in-Renal-Cell-Cancer-at-the-ASCO20-Virtual-Scientific-Program.html